References
- Ito S, Chapman KA, Kisling M, et al. Appropriate use of genetic testing in congenital heart disease patients. Curr Cardiol Rep. 2017; 19(3):24–24.
- Richards AA, Garg V. Genetics of congenital heart disease. CCR. 2010;6(2):91–97.
- Asoglu MR, Bears B, Turan S, et al. The factors associated with mode of delivery in fetuses with congenital heart defects. J Matern Fetal Neonatal Med. 2018;6:1–8.
- De Groote K, Vanhie E, Roets E, et al. Outcome after prenatal and postnatal diagnosis of complex congenital heart defects and the influence of genetic anomalies. Prenat Diagn. 2017;37(10):983–991.
- Quartermain MD, Hill KD, Goldberg DJ, et al. Prenatal diagnosis influences preoperative status in neonates with congenital heart disease: an analysis of the society of thoracic surgeons congenital heart surgery database. Pediatr Cardiol. 2019;40(3):489–496.
- Muntean I, Togănel R, Benedek T. Genetics of congenital heart disease: past and present. Biochem Genet. 2017;55(2):105–123.
- Turan S, Asoglu MR, Benziv RG, et al. Yield rate of chromosomal microarray analysis in fetuses with congenital heart defects. Eur J Obstet Gynecol Reprod Biol. 2018;221:172–176.
- Pergament E, Cuckle H, Zimmermann B, et al. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol. 2014;124(2 Pt 1):210–218.
- American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics, Committee on Genetics, Society for Maternal-Fetal Medicine. Practice bulletin no. 162: Prenatal diagnostic testing for genetic disorders. Obstet Gynecol. 2016;127(5):e108–22.
- Kirby ML, Hutson MR. Factors controlling cardiac neural crest cell migration. Cell Adh Migr. 2010;4(4):609–621.
- Botto LD, Lin AE, Riehle-Colarusso T, et al. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defect Res A. 2007;79(10):714–727.
- Wittman AT, Hashmi SS, Mendez-Figueroa H, et al. patient perception of negative noninvasive prenatal testing results. AJP Rep. 2016;06(04):e391–e406.
- Benachi A, Letourneau A, Kleinfinger P, et al. Cell-Free DNA analysis in maternal plasma in cases of fetal abnormalities detected on ultrasound examination. Obstet Gynecol. 2015;125(6):1330–1337.
- Reimers RM, Mason‐Suares H, Little SE, et al. When ultrasound anomalies are present: an estimation of the frequency of chromosome abnormalities not detected by cell‐free DNA aneuploidy screens. Prenatal Diagnosis. 2018;38(4):250–257.
- Pierpont ME, Brueckner M, Chung WK, et al. Genetic basis for congenital heart disease: revisited: a scientific statement from the American Heart Association. Circulation. 2018; 138(21):e653–e711.
- Shani H, Goldwaser T, Keating J, et al. Chromosomal abnormalities not currently detected by cell-free fetal DNA: a retrospective analysis at a single center. Am J Obstet Gynecol. 2016;214(6):729.e1–11.
- Beulen L, Faas BHW, Feenstra I, et al. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies. Ultrasound Obstet Gynecol. 2017;49(6):721–728.
- Harris JA, Francannet C, Pradat P, et al. The epidemiology of cardiovascular defects, part 2: a study based on data from three large registries of congenital malformations. Pediatr Cardiol. 2003;24(3):222–235.
- Hartman RJ, Rasmussen SA, Botto LD, et al. The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol. 2011;32(8):1147–1157.
- Committee opinion no. 640: Cell-free DNA screening for fetal aneuploidy. Obstet Gynecol. 2015;126(3):e31–7.
- Society for Maternal-Fetal Medicine (SMFM) Publications Committee. Prenatal aneuploidy screening using cell-free DNA. Am J Obstet Gynecol. 2015;212(6):711–716.